☆ 4.8 Article

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2

FRONTIERS IN IMMUNOLOGY (2021)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Spike mutation D614G alters SARS-CoV-2 fitness

Jessica A. Plante et al.

Summary: The D614G substitution in the SARS-CoV-2 spike protein enhances viral replication and infectivity in human lung epithelial cells, primary airway tissues, and hamsters. This variant may increase transmission in the upper respiratory tract and doesn't seem to significantly reduce vaccine efficacy. Further research on therapeutic antibodies targeting the circulating G614 virus is recommended.

NATURE (2021)

Add to Collection

Article Microbiology

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Allison J. Greaney et al.

Summary: Antibodies targeting the SARS-CoV-2 spike receptor-binding domain (RBD) are key in neutralizing antibody responses, and a deep mutational scanning method was used to assess the impact of all amino-acid mutations in the RBD on antibody binding with 10 human monoclonal antibodies. The study identified the clustered escape mutations in different surfaces of the RBD that correspond to structurally defined antibody epitopes, showing that even antibodies targeting the same surface can have distinct escape mutations.

CELL HOST & MICROBE (2021)

Add to Collection

Article Microbiology

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

Drew Weissman et al.

Summary: The D614G mutation in the spike protein of SARS-CoV-2 is not expected to hinder current vaccine development, as viruses with the G614 spike are more susceptible to neutralization, indicating that the mutation may not affect vaccine efficacy.

CELL HOST & MICROBE (2021)

Add to Collection

Article Medicine, General & Internal

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

D. M. Weinreich et al.

Summary: Recent data indicate that complications and death from Covid-19 may be related to high viral loads. In this trial involving nonhospitalized patients, a cocktail of two neutralizing monoclonal antibodies (REGN-COV2) reduced viral load, with a greater effect in patients with no immune response or high viral load at baseline. Safety outcomes were similar between REGN-COV2 dose groups and the placebo group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape

Zhiqiang Ku et al.

Summary: Antibody cocktails are a promising approach to prevent SARS-CoV-2 escape, with a combination of antibodies CoV2-06 and CoV2-14 identified as effective in preventing viral escape and providing protection in mice, offering new insights for treating COVID-19.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries

Rui Wang et al.

Summary: The study reveals many mutations on the RBD of the S protein, with the majority strengthening the binding between the RBD and host ACE2, indicating an evolution towards more infectious variants. Additionally, certain mutations found in different variants may weaken the binding between the RBD and antibodies, potentially compromising existing vaccines and antibody therapies. The study also identifies potential vaccine escape mutations that could pose a threat to current vaccines and antibody treatments.

GENOMICS (2021)

Add to Collection

Article Medicine, General & Internal

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Roujian Lu et al.

LANCET (2020)

Add to Collection

Article Multidisciplinary Sciences

Acidity enhancement through synergy of penta- and tetra-coordinated aluminum species in amorphous silica networks

Zichun Wang et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Microbiology

Identification of Human Single-Domain Antibodies against SARS-CoV-2

Yanling Wu et al.

CELL HOST & MICROBE (2020)

Add to Collection

Article Multidisciplinary Sciences

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

Rui Shi et al.

NATURE (2020)

Add to Collection

News Item Multidisciplinary Sciences

The coronavirus pandemic in five powerful charts

Ewen Callaway et al.

NATURE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Qianqian Li et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies

Alina Baum et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail

Johanna Hansen et al.

SCIENCE (2020)

Add to Collection

Editorial Material Biology

VIRUSES Neutralizing SARS-CoV-2

Eric Poeschla

ELIFE (2020)

Add to Collection

Article Biology

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Yiska Weisblum et al.

ELIFE (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2

Guangyu Zhou et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Add to Collection

Article Cell Biology

A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein

Yan Li et al.

CELL RESEARCH (2015)

Add to Collection

Article Multidisciplinary Sciences

Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

Xueling Wu et al.

SCIENCE (2010)

Add to Collection

Article Biochemical Research Methods

Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen

Kenneth Smith et al.

NATURE PROTOCOLS (2009)

Add to Collection

Article Biochemistry & Molecular Biology

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

E Traggiai et al.

NATURE MEDICINE (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.